LRRK2 and Parkinson disease: Moreover, astrocytes with the LRRK2 G2019S mutation transferred α-synuclein to neighboring neurons, leading to α-synuclein accumulation and neurodegeneration, suggesting that LRRK2 mutated astrocytes can mediate toxicity in the course of PD pathogenesis [71].